載入...
A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report
Bosutinib is a BCR-ABL tyrosine kinase inhibitor approved for the treatment of Philadelphia chromosome–positive chronic myelogenous leukemia. We report a case of bosutinib-induced interstitial granulomatous drug reaction in a 50-year-old Caucasian female with chronic myelogenous leukemia. Histologic...
Na minha lista:
| 發表在: | SAGE Open Med Case Rep |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6134482/ https://ncbi.nlm.nih.gov/pubmed/30214807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X18795075 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|